Thus, it is conceivable that there is a specific impact of the genetic reduction of FMRP or 4E‐BP2 in the translation of proteins involved in either the development of the hippocampus or in transmission and plasticity, which may explain the targeting of cognitive processes that become impaired in AD models. The gene discussed is FMR1; the disease is Alzheimer disease.